Pulmonary Hypertension News Forums Forums Research and Development Did you miss our top three read articles in May?

  • jsexton

    Member
    June 21, 2024 at 7:58 am

    What I found very interesting is that a lot of the new research is based on the “blocking” properties. Seralutinib, WinRevair and others in the pipeline look to be going after how can we block all these PH things from happening. Very interesting read. I can tell you in doing my research for 12 years with PH, you really have to use the Webster to understand more! lol Very good read! Thanks for shareing!

Log in to reply.